![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
(51) | INT.CL. | A61K 48/00 | |
A61K 38/16 | |||
A61K 38/17 | |||
A61K 38/48 | |||
A61K 35/17 | |||
A61K 35/28 | |||
A61K 35/30 | |||
A61K 35/545 | |||
C12N 5/00 | |||
C12N 9/64 |
(11) | Patento numeris | 3004329 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 14807405.7 |
Europos patento paraiškos padavimo data | 2014-06-04 | |
(97) | Europos patento paraiškos paskelbimo data | 2016-04-13 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2020-03-04 |
(46) | Apibrėžties vertimo paskelbimo data |
(86) | Numeris | PCT/US2014/040964 |
Data | 2014-06-04 |
(87) | Numeris | WO 2014/197638 |
Data | 2014-12-11 |
(30) | Numeris | Data | Šalis |
201361831428 P | 2013-06-05 | US | |
201461949847 P | 2014-03-07 | US |
(72) |
SLAWIN, Kevin, US
SPENCER, David, US
FOSTER, Aaron, Edward, US
|
(73) |
Bellicum Pharmaceuticals, Inc.,
2130 West Holcombe Boulevard Ste. 850, Houston, TX 77030,
US
|
(54) | METHODS FOR INDUCING PARTIAL APOPTOSIS USING CASPASE POLYPEPTIDES |
METHODS FOR INDUCING PARTIAL APOPTOSIS USING CASPASE POLYPEPTIDES |